Fetal and postnatal growth of children born to narcotic-dependent women
Related Experiment Videos
Insights
Heroin and methadone exposure in pregnancy did not significantly impact infant birth length after accounting for confounding factors. Postnatal growth at three years was comparable across all groups, suggesting no lasting height deficits from prenatal drug exposure.
Area of Science:
- Pediatrics
- Neonatal Abstinence Syndrome
- Maternal Health
Background:
- Prenatal exposure to opioids like heroin and methadone can affect child development.
- Understanding the long-term growth implications is crucial for clinical management.
Purpose of the Study:
- To investigate the effects of prenatal heroin and methadone exposure on birth length and 3-year stature.
- To differentiate the impact of drug exposure from associated confounding variables.
Main Methods:
- Comparative study of infants born to untreated heroin addicts, women on methadone maintenance, and a drug-free comparison group.
- Statistical adjustment for biological, demographic, and health-related variables.
- Assessment of birth length and 3-year stature.
Main Results:
- Adjusted birth lengths were similar across groups, indicating confounding factors influenced initial growth.
- At 3 years, mean height was comparable among all groups.
- Methadone-exposed children were shorter than heroin-exposed children after adjusting for birth length, parental height, and smoking.
Conclusions:
- Prenatal heroin and methadone effects on intrauterine growth are intertwined with associated factors.
- Postnatal growth in children exposed to narcotics during pregnancy is not more impaired than in a high-risk comparison group.
- Continued monitoring and environmental support are vital for the optimal development of these children.
Abstract:
We studied the effect of heroin and methadone on birth length and 3-year stature of children of untreated heroin addicts (n = 22), women receiving methadone maintenance therapy (95% were polydrug users) (n = 21), and a drug-free comparison group (n = 28), after adjustment for biologic, demographic, and health variables. The mean birth lengths of both groups of drug-exposed infants were significantly below that of a comparison group; however, group means were similar after adjustment for sex, race, prenatal care, pregnancy weight gain, obstetrical risk, maternal education, and smoking. At 3 years of age the mean height was comparable for all groups. When adjusted for birth length, parental height, and smoking, the methadone group was significantly shorter than children exposed to heroin in utero, and the comparison group assumed an intermediate position. These data indicate that the effect of heroin and methadone on intrauterine growth cannot be differentiated from that of associated factors, and that postnatal growth of children exposed to narcotics during pregnancy is no more impaired than that of a high-risk comparison group. Children of all three groups deserve continued observation and efforts to improve their environment in order that their full potential might be achieved.